CA Stock MarketDetailed Quotes
MDP Medexus Pharmaceuticals Inc
- 2.820
- +0.220+8.46%
15min DelayMarket Closed Dec 20 16:00 ET
69.52MMarket Cap23.11P/E (TTM)
2.820High2.610Low5.85KVolume2.650Open2.600Pre Close15.55KTurnover3.27052wk High0.03%Turnover Ratio24.65MShares1.47052wk Low0.122EPS TTM62.82MFloat Cap11.250Historical HighLossP/E (Static)22.27MShs Float0.880Historical Low-0.014EPS LYR8.08%Amplitude--Dividend TTM1.48P/B1Lot Size--Div YieldTTM
About Medexus Pharmaceuticals Inc Company
Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.
Company Profile
SymbolMDP
Company NameMedexus Pharmaceuticals Inc
Founded2013
MarketTSE
Employees82
Fiscal Year Ends03-31
Address10 King Street East Suite 600
CityToronto
CountryCAN
Zip CodeM5C 1C3
Phone+1 514 762-2626
Websitehttps://www.medexus.com
Company Executives
- Name
- Position
- Salary
- Kenneth d’Entremont
- Chief Executive Officer and Director
- --
- Richard Labelle
- Chief Operating Officer
- --
- Brendon Buschman
- Chief Financial Officer
- --
- Michael Mueller
- Chairman of the Board
- --
- Menassie Taddese, M.B.A.
- Independent Director
- --
- Benoit Gravel
- Independent Director
- --
- Stephen Nelson
- Independent Director
- --
- Dr. Harmony P. Garges, M.D.
- Independent Director
- --
- Nancy Phelan
- Independent Director
- --
- Ian C Wildgoose Brown
- General Counsel and Corporate Secretary
- --
Heat List
CA
Overall
Symbol
Price
% Chg
No Data